Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCORNAC: Prolonged Corticosteroid Treatment or N-Acetylcysteine for Severe Alcoholic Hepatitis
NCT06956482Phase 3Recruiting
- Sponsor
- CHU de Lille
- Start
- May 2026
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine, prednisolone in alcoholic hepatitis (AH), sponsored by CHU de Lille. Started May 2026; status: recruiting.
02
Drugs
acetylcysteineprednisolone
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT06956482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06956482.